Parkinson's, Alzheimer's, and motor neurone disease.
作者信息
Ben-Shlomo Y, Whitehead A S, Smith G D
出版信息
BMJ. 1996 Mar 23;312(7033):724. doi: 10.1136/bmj.312.7033.724.
Abstract
摘要
相似文献
1
Parkinson's, Alzheimer's, and motor neurone disease.
BMJ. 1996 Mar 23;312(7033):724. doi: 10.1136/bmj.312.7033.724.
2
Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism.
Neuroscience. 2002;113(3):485-92. doi: 10.1016/s0306-4522(02)00194-x.
3
Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?
Del Med J. 1987 Aug;59(8):533-4, 537.
4
A cortical vs. subcortical distinction of dementia contrasts with the unifying pathoetiology of Alzheimer's and Parkinson's disease.
Int J Neurosci. 1987 Feb;32(3-4):983-5. doi: 10.3109/00207458709043355.
5
Iron in the brain: implications for Parkinson's and Alzheimer's diseases.
Mt Sinai J Med. 1988 Jan;55(1):97-101.
6
Smoking-associated protection from Alzheimer's and Parkinson's disease.
Lancet. 1994 Feb 5;343(8893):356-7. doi: 10.1016/s0140-6736(94)91194-0.
7
[Smoking and neurological disorders].
Nihon Rinsho. 2013 Mar;71(3):423-9.
8
An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
Drug Metabol Drug Interact. 2003;19(4):223-40. doi: 10.1515/dmdi.2003.19.4.223.
9
Co-occurrence of post poliomyelitis motor neuron disease and parkinsonism: chance or related association?
Ital J Neurol Sci. 1993 Dec;14(9):652-3. doi: 10.1007/BF02339252.
10
The impact of obesity on neurodegenerative diseases.
Life Sci. 2017 Aug 1;182:22-28. doi: 10.1016/j.lfs.2017.06.002. Epub 2017 Jun 3.
引用本文的文献
1
Development of Halogenated-Chalcones Bearing with Dimethoxy Phenyl Head as Monoamine Oxidase-B Inhibitors.
Pharmaceuticals (Basel). 2022 Sep 16;15(9):1152. doi: 10.3390/ph15091152.
2
Motor Neuron Diseases in Sub-Saharan Africa: The Need for More Population-Based Studies.
Biomed Res Int. 2015;2015:298409. doi: 10.1155/2015/298409. Epub 2015 Aug 12.
3
Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
J Neurol. 2010 May;257(5):706-15. doi: 10.1007/s00415-009-5392-z. Epub 2009 Nov 28.
4
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
BMJ. 1998 Apr 18;316(7139):1191-6. doi: 10.1136/bmj.316.7139.1191.
5
Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):347-51. doi: 10.1136/jnnp.61.4.347.
6
Extrapyramidal signs should be sought more often in Alzheimer's disease.
BMJ. 1996 Jul 6;313(7048):45. doi: 10.1136/bmj.313.7048.45.
本文引用的文献
1
Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease.
Lancet. 1996 Jan 20;347(8995):159-60. doi: 10.1016/s0140-6736(96)90343-8.
2
Smoking and Alzheimer's disease: protective effect or differential survival bias?
Lancet. 1993 Sep 25;342(8874):793-4. doi: 10.1016/0140-6736(93)91547-y.
3
The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.
Neurology. 1994 Jul;44(7):1330-1. doi: 10.1212/wnl.44.7.1330.
4
5
Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene.
Lancet. 1994 Sep 17;344(8925):815. doi: 10.1016/s0140-6736(94)92370-1.
6
Mortality in relation to smoking: 40 years' observations on male British doctors.
BMJ. 1994 Oct 8;309(6959):901-11. doi: 10.1136/bmj.309.6959.901.
7
Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.
BMJ. 1995 Mar 11;310(6980):627-31. doi: 10.1136/bmj.310.6980.627.
8
Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study.
Am J Epidemiol. 1995 Dec 15;142(12):1300-5. doi: 10.1093/oxfordjournals.aje.a117597.
9
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
Neurology. 1995 Nov;45(11):1991-5. doi: 10.1212/wnl.45.11.1991.
10
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.
Ann Neurol. 1981 Dec;10(6):499-505. doi: 10.1002/ana.410100602.
Zotero 插件